Latham & Watkins advised CHEPLAPHARM on the offering. CHEPLAPHARM Arzneimittel GmbH announced the issuance of €750 million aggregate principal amount of New York law 144A/Reg S senior...
You must be a Standard 1 Year member to access this content.
Latham & Watkins has advised CHEPLAPHARM AG on the deal. CHEPLAPHARM AG (CHEPLAPHARM), a leading international platform for well-established branded medicines, announced its agreement for a...
You must be a Standard 1 Year member to access this content.
Sullivan & Cromwell advised Majorel on the deal, while Latham & Watkins advised the syndicate of banks. Majorel, a leading global provider of call centers, completed...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised the consortium of banks on the IPO of SUSE S.A. on the Frankfurt Stock Exchange. In the course of the IPO, 37.3...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised the consortium of banks on the IPO of SUSE S.A. on the Frankfurt Stock Exchange. In the course of the IPO, 37.3...
You must be a Standard 1 Year member to access this content.
